List of insiders holdings for Vigil Neuroscience Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Booth Bruce Director | 2025-05-23 20:46:39 | 5,000 5,836,874 | 5,841,874 | Form 4 |
| 2 | Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 2022-01-21 16:39:21 | 4,808,896 0 | 4,808,896 | Form 13D |
| 3 | AMGEN INC 10% Owner | 2022-01-11 21:33:29 | 3,206,281 0 | 3,206,281 | Form 13G |
| 4 | Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner | 2025-06-12 17:33:04 | 1,634,798 0 | 1,634,798 | Form 13D |
| 5 | Thorp Clay Director | 2022-05-17 21:06:52 | 3,000 1,556,030 | 1,559,030 | Form 4 |
| 6 | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund IV LP Former 10% Owner | 2022-01-13 16:06:53 | 0 616,786 | 616,786 | Form 4 |
| 7 | Magovcevic-Liebisch Ivana President and CEO | 2025-03-04 17:08:10 | 485,000 0 | 485,000 | Form 4 |
| 8 | Silber Christopher Chief Medical Officer | 2023-08-07 18:43:55 | 330,000 0 | 330,000 | Form 4 |
| 9 | Verni Christopher General Counsel | 2024-05-07 17:00:37 | 235,000 0 | 235,000 | Form 4 |
| 10 | Alexandria Venture Investments LLC 10% Owner | 2022-01-11 17:53:24 | 192,973 0 | 192,973 | Form 4 |
| 11 | Ziolkowski Jennifer Lynn Chief Financial Officer | 2025-03-04 17:09:35 | 156,000 0 | 156,000 | Form 4 |
| 12 | Papapetropoulos Spyros Chief Medical Officer | 2022-11-22 21:45:28 | 153,604 0 | 153,604 | Form 4 |
| 13 | Kaufmann Petra Chief Medical Officer | 2025-03-04 17:09:51 | 144,000 0 | 144,000 | Form 4 |
| 14 | Gray David L. F. Chief Science Officer | 2025-03-04 17:04:59 | 125,000 0 | 125,000 | Form 4 |
| 15 | Thackaberry Evan SVP, Head of Early Development | 2023-03-03 17:08:53 | 65,000 0 | 65,000 | Form 4 |
| 16 | Budd Haeberlein Samantha L. Director | 2025-05-23 20:41:53 | 17,000 0 | 17,000 | Form 4 |
| 17 | Thistle Mary Director | 2025-05-23 20:40:47 | 5,000 0 | 5,000 | Form 4 |
| 18 | Blanchard Cheryl R Director | 2025-05-23 20:41:42 | 5,000 0 | 5,000 | Form 4 |
| 19 | Koenig Gerhard Director | 2025-05-23 20:43:08 | 5,000 0 | 5,000 | Form 4 |
| 20 | Bruhn Suzanne Louise Director | 2025-05-23 20:44:02 | 5,000 0 | 5,000 | Form 4 |
| 21 | Vitorovic Stefan Director | 2025-05-23 20:45:31 | 5,000 0 | 5,000 | Form 4 |
| 22 | Gandhi Shaan-Chirag C Director | 2022-01-06 20:26:30 | 0 0 | 0 | Form 3 |
| 23 | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner | 2025-05-27 18:26:13 | 0 0 | 0 | Form 13D |